Hartman Institute for Therapeutic Organ Regeneration

Design and synthesis of boron containing potential pan-RAR inverse agonists.

TitleDesign and synthesis of boron containing potential pan-RAR inverse agonists.
Publication TypeJournal Article
Year of Publication2012
AuthorsDas BC, Tang X-Y, Evans T
JournalTetrahedron Lett
Volume53
Issue11
Pagination1316-1318
Date Published2012 Mar 14
ISSN0040-4039
Abstract

<p>We designed and successfully synthesized the compounds 5 and 8 as potential pan-RAR (retinoic acid receptor) agonists. These two compounds were designed based on an existing pan-RAR agonist (BMS493). We synthesized compound 5, in which the carboxylic acid group in BMS 493 was replaced by boronic ester; and compound 8, in which the double bond of BMS 493 was changed to an oxadiazole (as bioisosteres of double bond) ring. The two target molecules 5 and 8 were synthesized from the commercially available 7-bromo-4,4-dimethyl-3,4-dihydronaphthalen-1(2H)-one 1. Compound 1 was derivatized to intermediate 5,5-dimethyl-8-(phenylethynyl)-5,6-dihydronaphthalene-2 carbaldehyde 4 by using alkylation, dehydration, and metal exchange reactions. The intermediate 4 was further converted to 5 by using a Wittig reaction and to 8 by amide coupling and dehydration to give overall 18% and 33% yields, respectively, after 8 steps in each case.</p>

DOI10.1016/j.tetlet.2011.12.118
Alternate JournalTetrahedron Lett
PubMed ID23180890
PubMed Central IDPMC3505081
Grant ListR01 HL056182 / HL / NHLBI NIH HHS / United States
R21 AA020630 / AA / NIAAA NIH HHS / United States
R37 HL056182 / HL / NHLBI NIH HHS / United States
R56 AI093220 / AI / NIAID NIH HHS / United States

Weill Cornell Medicine
Hartman Institute for Therapeutic Organ Regeneration
1300 York Ave, Box 136 New York, NY 10065